Genmab — Januar 2017
-
Mon det skal tolkes positivt for Genmab "Samtidig ønsker præsidenten en gennemgang af processen omkring de amerikanske sundhedsmyndigheders, FDAs, godkendelsesproces af nye midler. Den proces skal nemlig gå meget hurtigere, lyder det fra præsidenten.
Reguleringen vil ifølge Donald Trump i den forbindelse bliver skåret på et niveau, der aldrig tidligere er set, skriver Bloomberg News."?
-
-
Nu må Nordea have fået læsset de sidste Bullx3 ud....er det noget med at de havde spredt
det ud til udgangen af januar? -
Bulder...på fredag??
-
Daratumumab mod alvorlig allergi: http://acsh.org/news/2017/01/30/blood-cancer-drug-could-treat-severe-allergies-10792
-
Lidt mere: "Let's get the antibodies up front as soon as possible" http://www.onclive.com/peer-exchange/mm-treatment-2017/which-proteasome-inhibitor-for-upfront-treatment-of-myeloma
-
NBI steg ikke på trods af Trump, men på grund af Trump: “I’ll oppose anything that makes it harder for smaller, younger companies to take the risk of bringing their product to a vibrantly competitive market,” Trump said after meeting with pharmaceutical executives Tuesday. “That includes price-fixing by the biggest dog in the market, Medicare, which is what's happening.” http://www.vox.com/policy-and-politics/2017/1/31/14455656/obamacare-trump-drug-prices
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind